Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
AirSculpt Technologies, Inc., together with its subsidiaries, provides body contouring procedure services in the United States. The company provides fat removal procedures across treatment areas; fat transfer procedures that use the patient's own fat cells to enhance breasts, buttocks, hips, or other areas. As of March 10, 2022, it operated 19 centers across 15 states.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $62.8M | $133.3M | $168.8M | $195.9M | $180.3M | $151.8M |
| Gross profit | — | — | — | — | — | — |
| Operating income | $10.0M | $15.8M | -$4.5M | $9.7M | -$1.6M | -$11.6M |
| Net income | $7.6M | $10.6M | -$14.7M | -$4.2M | -$8.0M | -$11.7M |
| Diluted EPS | — | -$0.01 | -$0.26 | -$0.08 | -$0.14 | -$0.19 |
| Operating cash flow | $14.0M | $26.6M | $24.4M | $24.0M | $11.3M | $3.1M |
| Free cash flow | $10.3M | $19.5M | $11.5M | $14.0M | -$2.7M | $692,000.00 |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 16.0% | 11.8% | -2.7% | 5.0% | -0.9% | -7.6% |
| Net margin | 12.1% | 7.9% | -8.7% | -2.2% | -4.4% | -7.7% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $51.0M | $42.5M | $39.2M | $39.4M | $44.0M | $35.0M | $33.4M | $39.4M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$5.0M | -$3.7M | -$3.9M | -$1.6M | $786,000.00 | -$9.8M | -$1.0M | -$1.8M |
| Net income | -$3.2M | -$6.0M | -$4.8M | -$2.8M | -$591,000.00 | -$9.5M | $1.3M | -$2.4M |
| Diluted EPS | -$0.06 | -$0.10 | -$0.08 | -$0.05 | -$0.01 | -$0.15 | $0.02 | -$0.03 |
| Operating cash flow | $3.4M | $1.8M | $2.7M | $868,000.00 | $5.0M | -$225,000.00 | -$2.5M | $5.3M |
| Free cash flow | -$576,000.00 | -$3.1M | -$815,000.00 | -$1.0M | $4.7M | -$405,000.00 | -$2.6M | $5.2M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -9.8% | -8.7% | -9.9% | -4.0% | 1.8% | -27.9% | -3.0% | -4.6% |
| Net margin | -6.3% | -14.2% | -12.3% | -7.2% | -1.3% | -27.2% | 3.8% | -6.1% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-20 | Feinstein Adam T | J | 5,169,820 | $0.00 | $0.00 | filing |
| 2026-05-12 | Higgins Kenneth | Award | 100,286 | $0.00 | $0.00 | filing |
| 2026-05-12 | Aaron Thomas J | Award | 100,286 | $0.00 | $0.00 | filing |
| 2026-05-12 | Chu Caroline | Award | 100,286 | $0.00 | $0.00 | filing |
| 2026-04-17 | Chernett Jorey | Buy | 40,000 | $2.54 | $101,600.00 | filing |
| 2026-04-14 | Chernett Jorey | Buy | 20,000 | $2.60 | $52,000.00 | filing |
| 2026-04-08 | Jashnani Yogesh· Chief Executive Officer | Award | 238,095 | $0.00 | $0.00 | filing |
| 2026-04-08 | Arthur Michael J· Chief Financial Officer | Award | 68,027 | $0.00 | $0.00 | filing |
| 2026-04-08 | WADMAN BRENT R· GENERAL COUNSEL | Award | 55,272 | $0.00 | $0.00 | filing |
| 2026-04-07 | Chernett Jorey | Buy | 60,000 | $2.93 | $175,800.00 | filing |
| 2026-04-03 | Chernett Jorey | Buy | 90,000 | $2.82 | $253,800.00 | filing |
| 2026-03-23 | Chernett Jorey | Buy | 50,000 | $2.91 | $145,500.00 | filing |
| 2026-03-20 | Chernett Jorey | Buy | 40,000 | $2.77 | $110,800.00 | filing |
| 2026-03-19 | Chernett Jorey | Buy | 77,702 | $2.64 | $205,133.28 | filing |
| 2026-03-18 | Jashnani Yogesh· Chief Executive Officer | Tax withholding | 38,379 | $2.79 | $107,077.41 | filing |
| 2026-03-17 | Chernett Jorey | Buy | 83,000 | $2.56 | $212,480.00 | filing |
| 2026-03-16 | Chernett Jorey | Buy | 105,848 | $2.43 | $257,210.64 | filing |
| 2026-03-11 | Chernett Jorey | Buy | 88,000 | $2.15 | $189,200.00 | filing |
| 2026-03-06 | Chernett Jorey | Buy | 45,600 | $2.00 | $91,200.00 | filing |
| 2026-03-04 | Chernett Jorey | Buy | 30,000 | $1.87 | $56,100.00 | filing |
| 2026-03-03 | Chernett Jorey | Buy | 80,000 | $1.71 | $136,800.00 | filing |
| 2026-02-03 | Jashnani Yogesh· Chief Executive Officer | Tax withholding | 24,217 | $2.58 | $62,479.86 | filing |
| 2026-01-24 | Arthur Michael J· Chief Financial Officer | Award | 147,059 | $0.00 | $0.00 | filing |
| 2025-10-27 | Jashnani Yogesh· Chief Executive Officer | Option exercise | 56,097 | — | — | filing |
Latest 24 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.